Filing Details

Accession Number:
0000898432-21-000772
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-09 21:40:27
Reporting Period:
2021-12-07
Accepted Time:
2021-12-09 21:40:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325618 Iradimed Corp IRMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
898243 B James Hawkins C/O Iradimed Corporation
1025 Willa Springs Dr.
Winter Springs FL 32708
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-07 18,743 $1.48 36,011 No 4 A Direct
Common Stock Disposition 2021-12-07 18,743 $47.07 17,268 No 4 S Direct
Common Stock Acquisiton 2021-12-07 4,222 $0.00 21,490 No 4 M Direct
Common Stock Acquisiton 2021-12-08 559 $1.48 22,049 No 4 A Direct
Common Stock Disposition 2021-12-08 559 $48.50 21,490 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 M Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2021-12-07 18,743 $0.00 18,743 $1.48
Common Stock Restricted Stock Units Disposition 2021-12-07 4,222 $0.00 4,222 $0.00
Common Stock Restricted Stock Units Acquisiton 2021-12-07 2,071 $0.00 2,071 $0.00
Common Stock Stock Options (Right to Buy) Disposition 2021-12-08 559 $0.00 559 $1.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2023-12-31 No 4 M Direct
2,037 No 4 M Direct
2,071 No 4 A Direct
9,441 2023-12-31 No 4 M Direct
Footnotes
  1. This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
  2. This transaction was executed in multiple trades at prices ranging from $46.30 to $48.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020 and 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
  4. Restricted Stock Units convert to common stock on a one-for-one basis.
  5. The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.